The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Clinical Trichophyton rubrum Strain Exhibiting Primary Resistance to Terbinafine
Open accessAbstract
The in vitro antifungal susceptibilities of six clinical Trichophyton rubrum isolates obtained sequentially from a single onychomycosis patient who failed oral terbinafine therapy (250 mg/day for 24 weeks) were determined by broth microdilution and macrodilution methodologies. Strain relatedness was examined by random amplified polymorphic DNA (RAPD) analyses. Data obtained from both broth micro- and macrodilution assays were in agreement and revealed that the six clinical isolates had greatly reduced susceptibilities to terbinafine. The MICs of terbinafine for these strains were >4 μg/ml, whereas they were <0.0002 μg/ml for the susceptible reference strains. Consistent with these findings, the minimum fungicidal concentrations (MFCs) of terbinafine for all six strains were >128 μg/ml, whereas they were 0.0002 μg/ml for the reference strain. The MIC of terbinafine for the baseline strain (cultured at the initial screening visit and before therapy was started) was already 4,000-fold higher than normal, suggesting that this is a case of primary resistance to terbinafine. The results obtained by the broth macrodilution procedure revealed that the terbinafine MICs and MFCs for sequential isolates apparently increased during the course of therapy. RAPD analyses did not reveal any differences between the isolates. The terbinafine-resistant isolates exhibited normal susceptibilities to clinically available antimycotics including itraconazole, fluconazole, and griseofulvin. However, these isolates were fully cross resistant to several other known squalene epoxidase inhibitors, including naftifine, butenafine, tolnaftate, and tolciclate, suggesting a target-specific mechanism of resistance. This is the first confirmed report of terbinafine resistance in dermatophytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Ghannoum, M. A., & Rice, L. B. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.4.501 · Cited by 1,785
Self-citationWeitzman, I., & Summerbell, R. C. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.2.240 · Cited by 966
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815
Ghannoum, M. A., Hajjeh, R. A., Scher, R., Konnikov, N., Gupta, A. K., Summerbell, R., Sullivan, S., Daniel, R., Krusinski, P., Fleckman, P., et al. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.107754 · Cited by 534
Self-citationTerbinafine: Mode of action and properties of the squalene epoxidase inhibition
RYDER, N. S. (1992) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1992.tb00001.x · Cited by 435
Self-citationJackson, C. J., Barton, R., & Evans, E. G. V. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.4.931-936.1999 · Cited by 235
Antifungals: mechanism of action and resistance, established and novel drugs
Georgopapadakou, N. H. (1998) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(98)80087-8 · Cited by 224
Mechanism of Action of Antifungal Drugs, with Special Reference to the Imidazole Derivatives
Borgers, M. (1980) · Clinical Infectious Diseases · doi:10.1093/clinids/2.4.520 · Cited by 215
Pfaller, M. A., Rhine-Chalberg, J., Redding, S. W., Smith, J., Farinacci, G., Fothergill, A. W., & Rinaldi, M. G. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.1.59-64.1994 · Cited by 197
Jessup, C. J., Warner, J., Isham, N., Hasan, I., & Ghannoum, M. A. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.1.341-344.2000 · Cited by 163
Self-citationPharmacokinetics and pharmacology of terbinafine and itraconazole
Leyden, J. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70483-9 · Cited by 129
Mechanisms of action of systemic antifungal agents
Elewski, B. E. (1993) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(09)80305-8 · Cited by 128
An evaluation of the in vitro activity of terbinafine
Jessup, C. J., Ghannoum, M. A., & Ryder, N. S. (2000) · Medical Mycology · doi:10.1080/mmy.38.2.155.159 · Cited by 102
Self-citationOral Treatments for Toenail Onychomycosis
Crawford, F., Young, P. J., Godfrey, C., Bell-Syer, S. E., Hart, R. L. D., Brunt, E. M., & Russell, I. T. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.6.811 · Cited by 90
Norris, H. A., Elewski, B. E., & Ghannoum, M. A. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70392-0 · Cited by 81
Self-citationFavre, B., & Ryder, N. S. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.443 · Cited by 80
Self-citationCurrent therapy of dermatophytosis
Degreef, H. J., & DEDONCKER, P. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(08)81263-7 · Cited by 79
Brandt, M. E., Pfaller, M. A., Hajjeh, R. A., Graviss, E. A., Rees, J., Spitzer, E. D., Pinner, R. W., & Mayer, L. W. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.4.812 · Cited by 72
Cited by
Singh, A., Masih, A., Khurana, A., Singh, P. K., Gupta, M., Hagen, F., Meis, J. F., & Chowdhary, A. (2018) · Mycoses · doi:10.1111/myc.12772 · Cited by 350
Yamada, T., Maeda, M., Alshahni, M. M., Tanaka, R., Yaguchi, T., Bontems, O., Salamin, K., Fratti, M., & Monod, M. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00115-17 · Cited by 343
Rudramurthy, S. M., Shankarnarayan, S. A., Dogra, S., Shaw, D., Mushtaq, K., Paul, R. A., Narang, T., & Chakrabarti, A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02522-17 · Cited by 273
Laube, S. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2003.08.003 · Cited by 124
Intra, J., Sarto, C., Mazzola, S., Fania, C., Tiberti, N., & Brambilla, P. (2019) · Mycopathologia · doi:10.1007/s11046-019-00360-9 · Cited by 20
Metadata
- Authors
- Mukherjee, P. K., Leidich, S. D., Isham, N., Leitner, I., Ryder, N. S., & Ghannoum, M. A.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2003-01
- Volume
- 47
- Issue
- 1
- Pages
- 82-86
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2167008723
- Cited by
- 291
- References
- 19
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.